Concord Wealth Partners Qiagen N.V. Transaction History

Concord Wealth Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$42.98 - $49.77 $14,699 - $17,021	-342 Reduced 83.41%	68 $3,000
Q1 2022 Apr 20, 2022	BUY	$42.23 - $54.3 $2,660 - $3,420	63 Added 18.16%	410 $20,000
Q4 2021 Jan 21, 2022	BUY	$50.62 - $56.47 $13,009 - $14,512	257 Added 285.56%	347 $19,000
Q3 2021 Nov 09, 2021	SELL	$46.55 - $56.83 $11,404 - $13,923	-245 Reduced 73.13%	90 $5,000
Q2 2021 Jul 29, 2021	BUY	$46.28 - $52.75 $10,875 - $12,396	235 Added 235.0%	335 $16,000
Q1 2021 May 13, 2021	SELL	$46.25 - $56.02 $4,625 - $5,602	-100 Reduced 50.0%	100 $5,000
Q4 2020 Feb 16, 2021	BUY	$46.09 - $54.74 $9,218 - $10,948	200 New	200 $11,000

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.92B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.